Skip to main content
. 2016 Dec 12;35(4):761–768. doi: 10.1097/HJH.0000000000001221

FIGURE 2.

FIGURE 2

Relations among the maximal concentrations of three doses of bremelanotide and changes in systolic BP (a) and changes in heart rate (b) after the first double-blind dose (controlled by placebo).